EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 22018D1758
Decision of the EEA Joint Committee No 24/2017 of 3 February 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1758]
Decision of the EEA Joint Committee No 24/2017 of 3 February 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1758]
Decision of the EEA Joint Committee No 24/2017 of 3 February 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1758]
OJ L 297, 22.11.2018, p. 30–30
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
22.11.2018 |
EN |
Official Journal of the European Union |
L 297/30 |
DECISION OF THE EEA JOINT COMMITTEE
No 24/2017
of 3 February 2017
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1758]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2016/1444 of 31 August 2016 amending Regulation (EU) No 37/2010 as regards the substance hydrocortisone aceponate (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following indent is added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
|
‘— |
32016 R 1444: Commission Implementing Regulation (EU) 2016/1444 of 31 August 2016 (OJ L 235, 1.9.2016, p. 8).’ |
Article 2
The text of Implementing Regulation (EU) 2016/1444 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 4 February 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 3 February 2017.
For the EEA Joint Committee
The President
Claude MAERTEN
(*1) No constitutional requirements indicated.